• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Virtual reality trains public to reverse opioid overdoses

Bioengineer by Bioengineer
September 14, 2020
in Health
Reading Time: 4 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Penn Nursing

The United States has seen a 200% increase in the rate of deaths by opioid overdose in the last 20 years. But many of these deaths were preventable. Naloxone, also called Narcan, is a prescription drug that reverses opioid overdoses, and in more than 40 states — including Pennsylvania — there is a standing order policy, which makes it available to anyone, without an individual prescription from a healthcare provider.

Members of the public can carry naloxone in case they encounter a person experiencing an opioid overdose. But how do you know if someone needs naloxone and how do you administer it? Health care providers are often trained to respond in these types of situations, and prior to the onset of COVID-19, public health organizations were offering in-person trainings to the public.

But how do we get even more people trained and motivated to save lives from opioid overdoses, especially in our current socially distanced world?

A group of interdisciplinary researchers from the University of Pennsylvania and the Philadelphia Department of Public Heath developed a virtual reality immersive video training aimed at doing just that. Their new study — published recently in Drug and Alcohol Prevention — shows that the VR training is just as effective as an in-person training at giving the public both the knowledge and the confidence they need to administer naloxone and save lives.

“Overdoses aren’t happening in hospitals and doctor’s offices,” says Nicholas Giordano, former Lecturer at Penn’s School of Nursing. “They’re happening in our communities: in parks, libraries, and even in our own homes. It’s crucial that we get the ability to save lives into the hands of the people on the front lines in close proximity to individuals at risk of overdose.”

The researchers adapted a 60 minute in-person training, the educational standard for health care providers, into a 9-minute immersive virtual reality video. Then the interdisciplinary team tested the VR training on members of the public at free naloxone giveaways and training clinics hosted by the Philadelphia Department of Health at local libraries. (The clinics were held in 2019 and early 2020, before the coronavirus pandemic made such events unsafe.)

Roughly a third of the 94 participants received one-on-one in-person instruction on how to administer naloxone, while the others watched the experimental VR training. After the initial training, participants answered questions about the training to determine if they’d learned enough information to safely administer naloxone in the case of an opioid overdose.

Before leaving the library, all participants were given the opportunity to receive whichever training they didn’t receive initially. Since the VR training was still in testing mode, the researchers wanted to ensure that all participants had full access to what they came for: knowledge of how to save lives.

“We were really pleased to discover that our VR training works just as well as an in-person training,” says Natalie Herbert, a 2020 graduate of Penn’s Annenberg School for Communication. “We weren’t looking to replace the trainings public health organizations are already offering; rather, we were hoping to offer an alternative for folks who can’t get to an in-person training, but still want the knowledge. And we’re excited to be able to do that.”

In addition to continuing to test their VR training, the researchers plan to begin making it available to the general public through partnerships with libraries, public health organizations, and other local stakeholders. With grant support from the Independence Blue Cross Foundation, the team will be disseminating and promoting the VR training throughout the Greater Philadelphia Area. Now, more than ever, the portability and immersive aspects of this VR raining can be leveraged to expand access to overdose training. For more information on how to experience the VR training, which can be used at home through Google Cardboard or other VR viewers, visit their website: https://www.virtualinnovation.org.

###

The paper, entitled “Leveraging Immersive Technology to Expand Access to Opioid Overdose Reversal Training in Community Settings: Results from a Randomized Controlled Equivalence Trial,” was published in the peer-reviewed journal Drug and Alcohol Prevention and is available online. “The study was conducted while both Giordano and Herbert were at Penn and prior to joining Emory University and Stanford University, respectively. In addition to them, other authors include: Sydney Axson, Yale School of Medicine; Leeann Siegel, Annenberg School; Kyle Cassidy, Annenberg School; Ann Marie Hoyt-Brennan, Penn Nursing; Clare Whitney, Penn Nursing; and Allison Herens, Philadelphia Department of Public Health.

This work was supported, in part, by a grant from the Independence Blue Cross Foundation.

Media Contact
Ed Federico
[email protected]

Original Source

https://www.nursing.upenn.edu/live/news/1743-virtual-reality-trains-public-to-reverse-opioid

Related Journal Article

http://dx.doi.org/10.1016/j.drugalcdep.2020.108160

Tags: AddictionDrugsMedicine/HealthPublic HealthSocial/Behavioral Science
Share13Tweet8Share2ShareShareShare2

Related Posts

Improving Sleep in Shift-Work Nurses: A Meta-Analysis

September 5, 2025
blank

Microgravity Impacts Testicular Health via C/EBP-β/MeCP2/Wnt Axis

September 5, 2025

New Insights in Thoraco-Lumbar Spine Modeling

September 5, 2025

Groundbreaking Discoveries in Energy Metabolism and Immune Dynamics Poised to Revolutionize Head and Neck Cancer Therapy

September 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Improving Sleep in Shift-Work Nurses: A Meta-Analysis

Microgravity Impacts Testicular Health via C/EBP-β/MeCP2/Wnt Axis

Natural Medicines Target Tumor Blood Vessels to Halt Cancer Progression

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.